Want to see AHR full AI Analyst Report?
American Healthcare REIT, Inc. (AHR) Ratios
American Healthcare REIT, Inc. Ratios
AHR's free cash flow for Q2 2026 was $70.93M. For the 2026 fiscal year, AHR's free cash flow was decreased by $-47.69M and operating cash flow was $118.62M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 0.37 | 0.37 | 0.20 | 0.61 | 0.30 |
| Quick Ratio | 0.37 | 0.35 | 0.19 | 0.57 | 0.28 |
| Cash Ratio | 0.13 | 0.08 | 0.03 | 0.12 | 0.07 |
| Solvency Ratio | 0.14 | 0.08 | 0.05 | 0.04 | 0.04 |
| Operating Cash Flow Ratio | 0.34 | 0.19 | 0.07 | 0.26 | 0.02 |
| Short-Term Operating Cash Flow Coverage | 0.54 | 0.26 | 0.08 | 0.47 | 0.02 |
| Net Current Asset Value | $ -1.75B | $ -1.83B | $ -2.82B | $ -2.80B | $ -2.42B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.31 | 0.42 | 0.66 | 0.59 | 0.55 |
| Debt-to-Equity Ratio | 0.51 | 0.83 | 2.38 | 2.02 | 1.58 |
| Debt-to-Capital Ratio | 0.34 | 0.45 | 0.70 | 0.67 | 0.61 |
| Long-Term Debt-to-Capital Ratio | 0.23 | 0.31 | 0.51 | 0.62 | 0.48 |
| Financial Leverage Ratio | 1.63 | 1.98 | 3.60 | 3.42 | 2.90 |
| Debt Service Coverage Ratio | 0.60 | 0.38 | 0.23 | 0.55 | 0.16 |
| Interest Coverage Ratio | 1.97 | 1.07 | 0.47 | 0.85 | 1.72 |
| Debt to Market Cap | 0.20 | 0.46 | 2.94 | 2.92 | 2.69 |
| Interest Debt Per Share | 10.67 | 15.30 | 48.18 | 44.39 | 39.01 |
| Net Debt to EBITDA | 4.37 | 5.69 | 9.18 | 11.84 | 15.18 |
| Profitability Margins | |||||
| Gross Profit Margin | 20.64% | 20.13% | 19.19% | 20.77% | 14.40% |
| EBIT Margin | 5.95% | 4.53% | 4.68% | 2.05% | 0.44% |
| EBITDA Margin | 15.91% | 15.24% | 17.44% | 14.45% | 12.61% |
| Operating Profit Margin | 7.47% | 6.61% | 4.13% | 5.60% | 10.98% |
| Pretax Profit Margin | 2.15% | -1.64% | -4.10% | -4.50% | -4.14% |
| Net Profit Margin | 3.09% | -1.83% | -3.84% | -5.03% | -3.78% |
| Continuous Operations Profit Margin | 3.13% | -1.72% | -4.14% | -4.54% | -4.21% |
| Net Income Per EBT | 143.49% | 111.58% | 93.76% | 111.68% | 91.36% |
| EBT Per EBIT | 28.81% | -24.77% | -99.35% | -80.36% | -37.69% |
| Return on Assets (ROA) | 1.29% | -0.84% | -1.56% | -1.70% | -1.04% |
| Return on Equity (ROE) | 2.10% | -1.67% | -5.63% | -5.81% | -3.02% |
| Return on Capital Employed (ROCE) | 3.70% | 3.86% | 2.47% | 2.14% | 4.00% |
| Return on Invested Capital (ROIC) | 22.20% | 3.23% | 1.68% | 1.99% | 3.16% |
| Return on Tangible Assets | 1.41% | -0.92% | -1.72% | -1.88% | -1.16% |
| Earnings Yield | 0.89% | -1.02% | -8.19% | -9.29% | -5.46% |
| Efficiency Ratios | |||||
| Receivables Turnover | 11.06 | 9.81 | 10.03 | 8.77 | 7.71 |
| Payables Turnover | 5.64 | 6.40 | 6.18 | 15.31 | 16.80 |
| Inventory Turnover | 0.00 | 84.92 | 77.15 | 64.81 | 57.16 |
| Fixed Asset Turnover | 8.34 | 12.63 | 8.16 | 0.42 | 0.34 |
| Asset Turnover | 0.42 | 0.46 | 0.41 | 0.34 | 0.28 |
| Working Capital Turnover Ratio | -3.96 | -2.35 | -2.68 | -3.24 | -4.10 |
| Cash Conversion Cycle | -31.67 | -15.50 | -17.89 | 23.40 | 31.97 |
| Days of Sales Outstanding | 33.00 | 37.21 | 36.39 | 41.60 | 47.31 |
| Days of Inventory Outstanding | 0.00 | 4.30 | 4.73 | 5.63 | 6.39 |
| Days of Payables Outstanding | 64.66 | 57.01 | 59.02 | 23.84 | 21.73 |
| Operating Cycle | 33.00 | 41.51 | 41.13 | 47.24 | 53.70 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 1.77 | 1.35 | 1.49 | 2.23 | 0.27 |
| Free Cash Flow Per Share | 1.00 | 0.64 | -0.02 | 1.15 | -0.93 |
| Dividend Paid and CapEx Coverage Ratio | 1.01 | 0.83 | 0.56 | 1.20 | 0.17 |
| Capital Expenditure Coverage Ratio | 2.29 | 1.92 | 0.99 | 2.07 | 0.22 |
| Operating Cash Flow Coverage Ratio | 0.17 | 0.09 | 0.03 | 0.05 | 0.01 |
| Operating Cash Flow to Sales Ratio | 0.13 | 0.09 | 0.05 | 0.09 | 0.01 |
| Free Cash Flow Yield | 2.12% | 2.27% | -0.14% | 8.71% | -7.06% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 112.05 | -98.00 | -12.22 | -10.77 | -18.31 |
| Price-to-Sales (P/S) Ratio | 3.46 | 1.79 | 0.47 | 0.54 | 0.69 |
| Price-to-Book (P/B) Ratio | 2.35 | 1.64 | 0.69 | 0.63 | 0.55 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 47.11 | 44.12 | -695.18 | 11.48 | -14.17 |
| Price-to-Operating Cash Flow Ratio | 26.54 | 21.08 | 8.86 | 5.92 | 48.86 |
| Price-to-Earnings Growth (PEG) Ratio | -0.46 | 1.34 | 1.00 | -0.15 | 0.01 |
| Enterprise Value Multiple | 26.10 | 17.46 | 11.87 | 15.59 | 20.67 |
| Enterprise Value | 9.39B | 5.51B | 3.85B | 3.64B | 3.30B |
| EV to EBITDA | 26.10 | 17.46 | 11.87 | 15.59 | 20.67 |
| EV to Sales | 4.15 | 2.66 | 2.07 | 2.25 | 2.61 |
| EV to Free Cash Flow | 56.58 | 65.44 | -3064.35 | 47.78 | -53.34 |
| EV to Operating Cash Flow | 31.88 | 31.27 | 39.06 | 24.66 | 183.98 |
| Tangible Book Value Per Share | 17.30 | 14.60 | 15.80 | 17.84 | 20.70 |
| Shareholders’ Equity Per Share | 20.00 | 17.31 | 19.23 | 21.15 | 23.88 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.46 | -0.05 | -0.01 | -0.01 | -0.02 |
| Revenue Per Share | 13.61 | 15.85 | 28.15 | 24.43 | 19.09 |
| Net Income Per Share | 0.42 | -0.29 | -1.08 | -1.23 | -0.72 |
| Tax Burden | 1.43 | 1.12 | 0.94 | 1.12 | 0.91 |
| Interest Burden | 0.36 | -0.36 | -0.88 | -2.20 | -9.31 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.05 | 0.05 | 0.06 | 0.06 | 0.03 |
| Stock-Based Compensation to Revenue | 0.01 | 0.00 | 0.00 | 0.00 | 0.01 |
| Income Quality | 4.16 | -4.95 | -1.28 | -2.01 | -0.34 |
Currency in USD
